Physician profile
James Thomas Cail
NPI 1669403085
$3,001.76
in general payments reported to CMS, 2019-2025
38 companies · $33.80 in 2025
The $33.80 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $1,048 · 2021: $113 · 2022: $326 · 2023: $397 · 2024: $261 · 2025: $33.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $692.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $691.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $357.15 | 2019-2024 | Invega Sustenna, Invega Trinza, Invega |
| Abbvie INC. | $309.67 | 2022-2024 | Vraylar |
| Otsuka America Pharmaceutical, INC. | $305.90 | 2019-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Amgen INC. | $304.24 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.97 | 2019-2020 | |
| Genentech USA, INC. | $159.67 | 2019-2020 | |
| Novo Nordisk INC | $126.15 | 2019-2020 | |
| Allergan, INC. | $119.64 | 2020 | |
| Corcept Therapeutics | $116.51 | 2019 | |
| Merck Sharp & Dohme LLC | $79.02 | 2019-2021 | |
| Pfizer INC. | $76.99 | 2019-2020 | |
| Lilly USA, LLC | $73.62 | 2020 | |
| Sunovion Pharmaceuticals INC. | $54.96 | 2019-2022 | |
| Antares Pharma, INC. | $49.88 | 2019-2024 | Xyosted |
| Bausch Health US, LLC | $44.57 | 2019-2020 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $44.40 | 2019-2020 | |
| Alkermes, INC. | $42.95 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.67 | 2020 | |
| Stryker Corporation | $41.40 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $37.73 | 2019 | |
| Astellas Pharma US INC | $36.95 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $36.20 | 2021-2023 | Ingrezza |
| Ironshore Pharmaceuticals INC. | $33.82 | 2019 | |
| Exact Sciences Corporation | $33.80 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Teva Pharmaceuticals USA, INC. | $32.76 | 2019-2022 | |
| Ibsa Pharma INC. | $29.87 | 2020 | |
| Amarin Pharma, INC. | $28.38 | 2019 | |
| Glaxosmithkline, LLC. | $27.84 | 2023 | Trelegy Ellipta |
| Adlon Therapeutics L.P. | $27.21 | 2020 | |
| Shire North American Group INC | $24.91 | 2019 | |
| Abbott Laboratories | $24.10 | 2020 | |
| Indivior INC. | $22.13 | 2022 | |
| Horizon Therapeutics Plc | $19.89 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $17.64 | 2024 | |
| Optinose US, INC. | $17.46 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.79 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.01 | 2019 | |
| Qol Medical, LLC | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cail listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.